A Placebo Controlled, Double Blind, Randomised, 8-week Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of AKR 202 in Patients With Osteoarthritis Pain

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This proof of concept study will be a placebo controlled, randomised, double blind, parallel study. The purpose of the study is to determine efficacy for AKR 202 in the treatment of osteoarthritis (OA) pain in the knee.
Epistemonikos ID: 35e4882148016713215ac5adddbb5789e1d6f4d2
First added on: May 11, 2024